Uroplasty (UPI) Inactive 10-Q2014 Q2 Quarterly report

Filed: 7 Nov 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: Advantage, average, Brett, calendar, Carryforward, dismissed, England, grandfathered, Hampshire, Heritage, Humana, IL, Island, jurisdiction, largest, Midwest, MN, National, nationwide, NGS, refocused, reorganization, Rhode, separately, South, Tricare, Vermont, VP, WI

Removed: absorption, agreement, AMA, annum, bank, base, BV, capacity, Category, characterized, charge, Columbia, continued, CPT, decline, derived, equity, expanded, expanding, facility, focused, Geleen, impairment, incur, instituting, intangible, January, loan, multiyear, occur, ongoing, overhead, pension, pilot, point, Rabobank, recognition, regulatory, relate, representing, secured, sheet, significantly, spend, spending, study, subsequent, support, translation

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

UPI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Uroplasty, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert Kill, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ ROBERT KILL

Robert Kill

Chief Executive Officer

Dated: November 7, 2013

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Uroplasty, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brett Reynolds, SVP and Chief Financial Officer, of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ BRETT REYNOLDS

Brett Reynolds

SVP and Chief Financial Officer

Dated: November 7, 2013

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.